NASDAQ · Financial Statements

IM Cannabis Corp. (IMCC) Revenue, Earnings & Financial Statements

$0.49 NASDAQ: IMCC Market Cap $813367

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

IM Cannabis Corp. most recently reported annual revenue of CAD 55.0M, a net loss of CAD 11.0M. Revenue grew at an average annual rate of 28.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

IM Cannabis Corp.: net profit was positive in 2 of 10 reported years; operating margin moved from -2.9% to -21.2%, a shift of -18.3 percentage points; the most recent year shows a net loss of CAD 11.0M.

Income Statement — 10 Years (CAD millions)

Metric2016201720182019202020212022202320242025
RevenueCAD 0CAD 4.0MCAD 5.0MCAD 9.0MCAD 16.0MCAD 34.0MCAD 54.0MCAD 49.0MCAD 54.0MCAD 55.0M
Operating ExpensesCAD 0CAD 5.0MCAD 2.0MCAD 19.0MCAD 24.0MCAD 57.0MCAD 85.0MCAD 62.0MCAD 64.0MCAD 66.0M
Operating ProfitCAD 0CAD 0CAD 3.0M−CAD 10.0M−CAD 8.0M−CAD 23.0M−CAD 31.0M−CAD 13.0M−CAD 10.0M−CAD 12.0M
Operating Margin—-2.9%59.3%-113.2%-51.9%-67.6%-56.7%-26.2%-18.9%-21.2%
Other IncomeCAD 0CAD 0CAD 0CAD 3.0M−CAD 20.0MCAD 23.0MCAD 5.0MCAD 3.0M−CAD 3.0MCAD 0
InterestCAD 0CAD 0CAD 0CAD 1.0MCAD 21.0MCAD 1.0MCAD 2.0MCAD 4.0MCAD 4.0MCAD 3.0M
DepreciationCAD 0CAD 0CAD 0CAD 1.0MCAD 1.0MCAD 6.0MCAD 7.0MCAD 3.0MCAD 2.0MCAD 2.0M
Profit Before TaxCAD 0CAD 0CAD 3.0M−CAD 7.0M−CAD 28.0MCAD 0−CAD 26.0M−CAD 9.0M−CAD 13.0M−CAD 12.0M
Tax rate (%)0.0%-192.8%22.0%-1.2%-0.9%-304.9%4.4%-8.2%8.0%-0.8%
Net ProfitCAD 0CAD 1.0MCAD 2.0M−CAD 7.0M−CAD 29.0M−CAD 18.0M−CAD 189.0M−CAD 9.0M−CAD 11.0M−CAD 11.0M
EPS−CAD 9.00−CAD 69.60CAD 18.00−CAD 414.00−CAD 342.00−CAD 1188.00−CAD 4856.40−CAD 133.50−CAD 135.30−CAD 80.10

Quarterly Results — Last 12 Quarters (CAD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
RevenueCAD 11.0MCAD 12.0MCAD 15.0MCAD 14.0MCAD 13.0MCAD 13.0MCAD 13.0MCAD 14.0MCAD 11.0MCAD 9.0MCAD 8.0MCAD 2.0M
Operating ExpensesCAD 16.0MCAD 18.0MCAD 12.0MCAD 13.0MCAD 33.0MCAD 12.0MCAD 13.0MCAD 18.0MCAD 14.0MCAD 10.0MCAD 10.0MCAD 5.0M
Operating Profit−CAD 5.0M−CAD 6.0MCAD 3.0MCAD 1.0M−CAD 20.0MCAD 0CAD 0−CAD 4.0M−CAD 3.0M−CAD 2.0M−CAD 2.0M−CAD 3.0M
Operating Margin-48.3%-46.7%19.4%6.9%-147.6%1.3%-2.8%-30.0%-25.1%-19.3%-27.5%-184.4%
InterestCAD 0CAD 1.0MCAD 1.0MCAD 0CAD 0CAD 0CAD 2.0MCAD 0CAD 1.0MCAD 1.0MCAD 3.0MCAD 2.0M
Profit Before Tax−CAD 3.0M−CAD 6.0M−CAD 4.0M−CAD 1.0M−CAD 1.0MCAD 0CAD 0−CAD 4.0M−CAD 6.0M−CAD 3.0M−CAD 4.0M−CAD 5.0M
Tax rate (%)-30.4%1.8%19.5%2.4%3.7%-19.9%11.8%-3.8%-0.1%1.6%1.1%5.2%
Net Profit−CAD 3.0M−CAD 6.0M−CAD 3.0M−CAD 1.0M−CAD 1.0MCAD 0CAD 0−CAD 4.0M−CAD 5.0M−CAD 2.0M−CAD 4.0M−CAD 7.0M
EPSCAD 0.00−CAD 75.60−CAD 40.80−CAD 12.30CAD 0.00CAD 2.70−CAD 2.70−CAD 22.50CAD 0.00−CAD 11.40−CAD 0.47−CAD 10.05

Over the 10 years reported for IM Cannabis Corp., cash stood at CAD 3.0M in the latest year, shareholders' equity was CAD 271.0M, current assets covered current liabilities 0.68 times.

Balance Sheet — 10 Years (CAD millions)

Metric2016201720182019202020212022202320242025
Total AssetsCAD 0CAD 0CAD 0CAD 31.0MCAD 38.0MCAD 287.0MCAD 61.0MCAD 49.0MCAD 39.0MCAD 32.0M
Current AssetsCAD 0CAD 0CAD 0CAD 24.0MCAD 27.0MCAD 84.0MCAD 33.0MCAD 24.0MCAD 23.0MCAD 23.0M
CashCAD 0CAD 0CAD 0CAD 14.0MCAD 9.0MCAD 14.0MCAD 2.0MCAD 2.0MCAD 1.0MCAD 3.0M
InventoryCAD 0CAD 0CAD 0CAD 5.0MCAD 8.0MCAD 31.0MCAD 17.0MCAD 10.0MCAD 3.0MCAD 4.0M
ReceivablesCAD 0CAD 0CAD 0CAD 2.0MCAD 6.0MCAD 31.0MCAD 11.0MCAD 11.0MCAD 17.0MCAD 13.0M
Fixed AssetsCAD 0CAD 0CAD 0CAD 4.0MCAD 6.0MCAD 48.0MCAD 7.0MCAD 6.0MCAD 4.0MCAD 4.0M
Capital Work in ProgressCAD 0CAD 0CAD 0CAD 0CAD 0CAD 0CAD 0CAD 0CAD 0CAD 0
InvestmentsCAD 0CAD 0CAD 0CAD 1.0MCAD 2.0MCAD 2.0MCAD 2.0MCAD 2.0MCAD 2.0MCAD 2.0M
Other AssetsCAD 0CAD 0CAD 0CAD 0CAD 0CAD 121.0MCAD 10.0MCAD 10.0MCAD 7.0MCAD 2.0M
Total LiabilitiesCAD 0CAD 0CAD 0CAD 5.0MCAD 26.0MCAD 82.0MCAD 37.0MCAD 35.0MCAD 36.0MCAD 35.0M
Current LiabilitiesCAD 0CAD 0CAD 0CAD 3.0MCAD 6.0MCAD 51.0MCAD 34.0MCAD 33.0MCAD 35.0MCAD 34.0M
BorrowingsCAD 0CAD 0CAD 0CAD 1.0MCAD 1.0MCAD 29.0MCAD 12.0MCAD 14.0MCAD 18.0MCAD 16.0M
Other LiabilitiesCAD 0CAD 0CAD 0CAD 4.0MCAD 25.0MCAD 53.0MCAD 25.0MCAD 21.0MCAD 18.0MCAD 19.0M
EquityCAD 26.0MCAD 26.0MCAD 0CAD 26.0MCAD 37.0MCAD 238.0MCAD 246.0MCAD 254.0MCAD 265.0MCAD 271.0M
ReservesCAD 11.0MCAD 11.0MCAD 10.0MCAD 25.0MCAD 11.0MCAD 201.0MCAD 23.0MCAD 14.0MCAD 5.0M−CAD 1.0M

For IM Cannabis Corp., operating cash flow was positive in 1 of 10 reported years; free cash flow in the latest year was CAD 5.0M; free cash flow was positive in 1 of 10 years; financing activities used CAD 5.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (CAD millions)

Metric2016201720182019202020212022202320242025
Operating Cash FlowCAD 0CAD 0CAD 0−CAD 6.0M−CAD 8.0M−CAD 34.0M−CAD 13.0M−CAD 8.0M−CAD 1.0MCAD 5.0M
Investing Cash FlowCAD 0−CAD 1.0M−CAD 1.0M−CAD 5.0M−CAD 7.0M−CAD 14.0M−CAD 3.0M−CAD 2.0M−CAD 1.0M−CAD 1.0M
Financing Cash FlowCAD 0CAD 0CAD 0CAD 2.0MCAD 7.0MCAD 13.0M−CAD 2.0MCAD 8.0MCAD 4.0M−CAD 5.0M
Net Cash FlowCAD 0CAD 0CAD 7.0MCAD 6.0M−CAD 5.0MCAD 5.0M−CAD 11.0M−CAD 1.0M−CAD 1.0MCAD 2.0M
Free Cash FlowCAD 0−CAD 1.0M−CAD 1.0M−CAD 8.0M−CAD 11.0M−CAD 39.0M−CAD 14.0M−CAD 9.0M−CAD 1.0MCAD 5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.91
FCF Yield-384.03%
Quick Ratio0.55
Interest Coverage-1.43
Return 1Y-98.55%
Return 3Y-99.29%
Return 5Y-99.99%

IM Cannabis Corp. (IMCC) financials — frequently asked questions

What is IM Cannabis Corp.'s annual revenue?

IM Cannabis Corp. (IMCC) reported annual revenue of CAD 55.0M in its most recent fiscal year.

What is IM Cannabis Corp.'s net profit?

IM Cannabis Corp. (IMCC) reported a net loss of CAD 11.0M in its most recent fiscal year.

What is IMCC EV/EBITDA?

IM Cannabis Corp.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.91. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Drug Manufacturers - Specialty & Generic stocks

TEVA revenue $17.3BZTS revenue $9.5BVTRS revenue $14.3BELAN revenue $4.7BRDY revenue $353.5BALKS revenue $1.5BAMRX revenue $3.0BLNTH revenue $1.5BSUPN revenue $719.0MBHC revenue $10.3BAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
IMCC Overview IMCC Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.